MX2024008024A - Cristal de compuesto de piperidina sustituida, sales de compuesto de piperidina sustituida y cristales de estas. - Google Patents

Cristal de compuesto de piperidina sustituida, sales de compuesto de piperidina sustituida y cristales de estas.

Info

Publication number
MX2024008024A
MX2024008024A MX2024008024A MX2024008024A MX2024008024A MX 2024008024 A MX2024008024 A MX 2024008024A MX 2024008024 A MX2024008024 A MX 2024008024A MX 2024008024 A MX2024008024 A MX 2024008024A MX 2024008024 A MX2024008024 A MX 2024008024A
Authority
MX
Mexico
Prior art keywords
piperidine compound
substituted piperidine
crystals
salts
crystal
Prior art date
Application number
MX2024008024A
Other languages
English (en)
Spanish (es)
Inventor
Nobuaki Sato
Ikuo Kushida
Yoko Ito
Takashi Fukuyama
So Yasui
Taro ASABA
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Publication of MX2024008024A publication Critical patent/MX2024008024A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
MX2024008024A 2022-01-14 2023-01-12 Cristal de compuesto de piperidina sustituida, sales de compuesto de piperidina sustituida y cristales de estas. MX2024008024A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022004608 2022-01-14
PCT/JP2023/000561 WO2023136279A1 (ja) 2022-01-14 2023-01-12 置換ピペリジン化合物の結晶並びに置換ピペリジン化合物の塩及びそれらの結晶

Publications (1)

Publication Number Publication Date
MX2024008024A true MX2024008024A (es) 2024-07-15

Family

ID=87279104

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024008024A MX2024008024A (es) 2022-01-14 2023-01-12 Cristal de compuesto de piperidina sustituida, sales de compuesto de piperidina sustituida y cristales de estas.

Country Status (10)

Country Link
US (1) US20250051322A1 (https=)
EP (1) EP4438602A4 (https=)
JP (1) JPWO2023136279A1 (https=)
KR (1) KR20240134870A (https=)
CN (1) CN118451076A (https=)
AU (1) AU2023206823A1 (https=)
CA (1) CA3243267A1 (https=)
MX (1) MX2024008024A (https=)
TW (1) TW202334120A (https=)
WO (1) WO2023136279A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7591592B2 (ja) * 2022-01-14 2024-11-28 エーザイ・アール・アンド・ディー・マネジメント株式会社 置換ピペリジン化合物を含有する医薬

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG34208A1 (en) 1995-03-01 1996-12-06 Guy Andrew Vaz Blast and fragment resistant polyurethane boot sole for safety footwear
EP0828751A4 (en) 1995-05-05 1999-01-20 Human Genome Sciences Inc HUMAN NEUROPEPTIDE RECEPTOR
US6309854B1 (en) 1996-12-17 2001-10-30 Smithkline Beecham Corporation Polynucleotides encoding ligands of the neuropeptide receptor HFGAN72
US6159605A (en) 1997-02-18 2000-12-12 Dainichiseika Color & Chemicals Mfg. Co., Ltd. Ink-jet recording sheet
US5935814A (en) 1997-04-30 1999-08-10 Smithkline Beecham Corporation Polynucleotides encoding HFGAN72Y receptor
US6020157A (en) 1997-04-30 2000-02-01 Smithkline Beecham Corporation Polynucleotides encoding HFGAN72X receptor
US6166193A (en) 1997-07-25 2000-12-26 Board Of Regents, University Of Texas System Polynucleotides encoding MY1 receptor
KR100327888B1 (ko) 1999-07-14 2002-03-09 정숭렬 도로포장 파손촉진 시험장치의 무선제어 시스템
TW201444849A (zh) * 2013-03-13 2014-12-01 Janssen Pharmaceutica Nv 經取代的7-氮雜雙環類及其作為食慾激素受體調節劑之用途
EP3896060B1 (en) * 2018-12-12 2023-08-16 Takeda Pharmaceutical Company Limited Heterocyclic compound
TWI888599B (zh) * 2020-07-17 2025-07-01 日商衛材R&D企管股份有限公司 取代哌啶化合物及其用途

Also Published As

Publication number Publication date
CN118451076A (zh) 2024-08-06
EP4438602A1 (en) 2024-10-02
TW202334120A (zh) 2023-09-01
CA3243267A1 (en) 2025-04-10
US20250051322A1 (en) 2025-02-13
KR20240134870A (ko) 2024-09-10
WO2023136279A1 (ja) 2023-07-20
AU2023206823A1 (en) 2024-07-11
JPWO2023136279A1 (https=) 2023-07-20
EP4438602A4 (en) 2025-11-19

Similar Documents

Publication Publication Date Title
CL2023003041A1 (es) Derivados de triazina que tienen actividad inhibidora de la replicación del virus y composición farmacéutica
JOP20220155A1 (ar) مشتقات البيرازول مفيدة كعوامل مضادة للسرطان
ZA202209563B (en) Biaryl derivatives as yap/taz-tead protein-protein interaction inhibitors
EP4282486A3 (en) Complement factor b inhibitor, and pharmaceutical composition thereof, preparation method therefor and use thereof
SA519410865B1 (ar) مركب حلقي شبيه بكُومارين بوصفه مثبط mek واستخدامه
NZ793536A (en) Imidazolidinone derivatives and medical use thereof
NO20082389L (no) 2,3,4-trifenylimidazolinderivater som inhibitor av interaksjonen mellom P53- og MDM2-proteiner for anvendelse som antikreftmidler
MY140638A (en) New heterocyclic compounds, which are active as inhibitors of beta-lactamases
WO2019178191A8 (en) O-glycoprotein-2-acetamido-2-deoxy-3-d-glycopyranosidase inhibitors
SA522431777B1 (ar) مشتقات ألفا -d- جالاكتو بيرانوسيد
MX2017001624A (es) Sal de derivado de piridina monociclico y su cristal.
MX2023006854A (es) Forma cristalina de tolebrutinib, metodo de preparacion y uso de la misma.
MX2025000291A (es) Compuesto heterocíclico capaz de inhibir prmt5•mta y uso del mismo
CO5560555A2 (es) Cristales de derivado de hidroxinorefedrina
PE20080342A1 (es) Inhibidores de proteasa de hiv de 2-(amino-sustituido)-benzotiazol sulfonamida
MX2024015245A (es) Compuestos utiles como moduladores de la autofagia mediada por chaperonas
JOP20230028A1 (ar) مشتقات سبيروبيبريدينيل مستبدل بأريل غير متجانس واستخدامات صيدلانية لها
PH12020552186A1 (en) Cyanotriazole compounds and uses thereof
MX2024008024A (es) Cristal de compuesto de piperidina sustituida, sales de compuesto de piperidina sustituida y cristales de estas.
MX2023009603A (es) Formas cristalinas de un modulador de somatostatina.
MX2021009774A (es) Sal de un compuesto pentaciclico y su cristal.
MX2021004379A (es) Nuevos derivados amino-pirimidonil-piperidinilo, un proceso para su preparacion y composiciones farmaceuticas que los contienen.
DE602005025493D1 (de) Entzündungshemmende wirkstoffe
JOP20220158A1 (ar) مشتق أمينو أريل جديد مفيد كمثبط لثنائي أسيل غليسيرول أسيل ترانسفيراز 2 diacylglycerol acyltransferase 2 واستخدامه
ATE473212T1 (de) Hiv-inhibierende 2-(4-cyanophenyl)-6- hydroxylaminopyrimidine